Early Versus Delayed Skin Staple Removal Following Cesarean Delivery in the Obese Patient
NCT ID: NCT01114451
Last Updated: 2021-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
292 participants
INTERVENTIONAL
2009-10-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cesarean Wound Closure in Women With BMI 40 or Greater
NCT02549131
Sutures vs. Staples Skin Closure After C-section in Obese Patients
NCT01820221
Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery
NCT02466776
Cesarean Trial of Staples vs. Sutures
NCT01211600
Staples Versus Suture for Cesarean Wound Closure
NCT01008449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One such intervention is the delayed removal of surgical skin staples. Skin staplers, which were first introduced in the 1980's, were "grandfathered" through the United States Food and Drug Administration (FDA) approval process, and have since become a widely utilized technique for skin closure. Although neither the FDA nor device manufacturers make a specific recommendation, skin staples are commonly left in situ anywhere from 3 - 10 days.
The physiologic rationale for delayed staple removal is unclear. Wound healing involves four main stages including hemostasis, inflammation, granulation, and remodeling. Each phase can be further broken down into overlapping steps. Reapproximation of the skin edges with staples enables epithelialization, resulting in wound closure by a thin layer of cells by 48 hours post-operatively. Although overall wound healing appears to be delayed in the setting of obesity, whether the specific process of epithelialization is affected is unknown. Therefore, there may not be a physiologic basis for delaying staple removal in obese women.
Furthermore, delayed staple removal has potentially negative effects on patient care that may not be balanced by clinical benefits. Delayed staple removal may be associated with prolongation of patient discomfort, additional clinical visits and increased associated costs. These issues caused us to question whether the practice of delayed skin staple removal in obese women is warranted.
Therefore, this clinical trial is designed to compare wound healing outcomes after cesarean following early (postoperative day #3) versus delayed (postoperative day #7 - 10) skin staple removal in the obese patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Staple Removal
Skin staple removal on post-operative day #3
Removal of surgical skin staples
Skin staples will be removed using standard technique with subsequent placement of steri-trips
Delayed Staple Removal
Skin staple removal on post-operative day 7-10
Removal of surgical skin staples
Skin staples will be removed using standard technique with subsequent placement of steri-trips
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Removal of surgical skin staples
Skin staples will be removed using standard technique with subsequent placement of steri-trips
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index ≥ 30 kg/m2
* Transverse (Pfannenstiel or Joel-Cohen) skin incision
* Subcutaneous wound depth ≥ 2 cm
* Surgical staple skin closure
Exclusion Criteria
* Non-staple skin closure
* Wound complication (superficial dehiscence, abscess, seroma, hematoma, cellulitis)
* Any complication necessitating prolonged hospitalization
18 Years
52 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prisma Health-Upstate
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francis S Nuthalapaty, MD
Role: PRINCIPAL_INVESTIGATOR
Prisma Health-Upstate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Greenville Memorial Hospital
Greenville, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nuthalapaty FS, Rouse DJ. The impact of obesity on obstetrical practice and outcome. Clin Obstet Gynecol. 2004 Dec;47(4):898-913; discussion 980-1. doi: 10.1097/01.grf.0000135358.34673.48. No abstract available.
Sarsam SE, Elliott JP, Lam GK. Management of wound complications from cesarean delivery. Obstet Gynecol Surv. 2005 Jul;60(7):462-73. doi: 10.1097/01.ogx.0000166603.43959.aa.
Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery. Am J Obstet Gynecol. 2005 Nov;193(5):1607-17. doi: 10.1016/j.ajog.2005.03.063.
American College of Obstetricians and Gynecologists. ACOG Committee Opinion number 315, September 2005. Obesity in pregnancy. Obstet Gynecol. 2005 Sep;106(3):671-5. doi: 10.1097/00006250-200509000-00054.
Walsh C, Scaife C, Hopf H. Prevention and management of surgical site infections in morbidly obese women. Obstet Gynecol. 2009 Feb;113(2 Pt 1):411-5. doi: 10.1097/AOG.0b013e3181945625. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00002576
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.